Xiaojian Ni
- Topics
- RNA modifications and cancer (5 papers)Peptidase Inhibition and Analysis (4 papers)Ubiquitin and proteasome pathways (4 papers)
- Journals
- SHILAP Revista de lepidopterologíaGeneExperimental Cell Research
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Xiaojian Ni
31 papers receiving 469 citations
Peers
Comparison fields: 5 of 68
- Molecular Biology 263
- Oncology 201
- Cancer Research 185
- Pulmonary and Respiratory Medicine 60
- Immunology 54
Countries citing papers authored by Xiaojian Ni
This map shows the geographic impact of Xiaojian Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojian Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojian Ni more than expected).
Fields of papers citing papers by Xiaojian Ni
This network shows the impact of papers produced by Xiaojian Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojian Ni. The network helps show where Xiaojian Ni may publish in the future.
Co-authorship network of co-authors of Xiaojian Ni
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojian Ni. A scholar is included among the top collaborators of Xiaojian Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojian Ni. Xiaojian Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 3 | |
| 5 | 4 | |
| 6 | 1 | |
| 7 | 4 | |
| 8 | 6 | |
| 9 | 4 | |
| 10 | 4 | |
| 11 | 30 | |
| 12 | 12 | |
| 13 | 11 | |
| 14 | 27 | |
| 15 | 7 | |
| 16 | 27 | |
| 17 | 29 | |
| 18 | 15 | |
| 19 | 35 | |
| 20 | 8 |
About Xiaojian Ni
Xiaojian Ni is a scholar working on Cancer Research, Oncology and Physiology, having authored 34 papers that have together received 475 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Peptidase Inhibition and Analysis (4 papers) and Ubiquitin and proteasome pathways (4 papers). The work is most often cited by research in Cancer Research (185 citations), Oncology (201 citations) and Molecular Biology (263 citations). Xiaojian Ni has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Yingchun Zhao, Xiaoming Zha, Zhixian He, Shui Wang, Tiansong Xia, Xiaoan Liu, Bohao Zheng, Qiang Ding, Wenbin Zhou and Jingjing Ma. Their work appears in journals such as SHILAP Revista de lepidopterología, Gene and Experimental Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.